Matarazzo MG, Sarpietro G, Fiorito D, Di Pasqua S, et al. Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study. Eur J Obstet Gynecol Reprod Biol 2021;263:67-71.
PMID: 34167036